<!DOCTYPE html>
<html lang='en'>
  <head>
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-PK63DK');</script>
    <meta content='text/html; charset=UTF-8' http-equiv='Content-Type'>
    <meta charset='utf-8'>
    <meta content='width=device-width, initial-scale=1, shrink-to-fit=no' name='viewport'>
    <link crossorigin='anonymous' href='https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/css/bootstrap.min.css' integrity='sha384-WskhaSGFgHYWDcbwN70/dfYBj47jz9qbsMId/iRN3ewGhXQFZCSftd1LZCfmhktB' rel='stylesheet'>
    <link href='/styles.css' rel='stylesheet'>
    <title>Resverlogix Closes $50 Million Private Placement With ...</title>
    <script async='async' src='https://www.googletagservices.com/tag/js/gpt.js'></script><script>var googletag=googletag ||{}; googletag.cmd=googletag.cmd || [];</script><script>googletag.cmd.push(function(){googletag.defineSlot('\/1010898\/sgforums_interstitial', [ 1.0 , 1.0], 'div-gpt-ad-1528181032761-0').setTargeting('forum', ['3513']).setTargeting('topic', ['489283']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_leaderboard', [[ 728.0 , 90.0], [ 970.0 , 250.0]], 'div-gpt-ad-1528181032761-1').setTargeting('forum', ['3513']).setTargeting('topic', ['489283']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_mpu', [ 300.0 , 250.0], 'div-gpt-ad-1528181032761-2').setTargeting('forum', ['3513']).setTargeting('topic', ['489283']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_supersky', [ 160.0 , 600.0], 'div-gpt-ad-1528181032761-3').setTargeting('forum', ['3513']).setTargeting('topic', ['489283']).addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices();});</script>
  </head>
  <body>
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PK63DK"height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <div class='container'>
      <a href='/'>Home</a>
      >
      <a href='/forums/3513/'>PR Newswire Asia</a>
      <h1>Resverlogix Closes $50 Million Private Placement With ...</h1>
      <nav class='pagination'>
      </nav>
      <ul class='list-group posts'>
        <li class='list-group-item post'>
          <div class='row'>
            <div class='col-md-2 meta'>
              <div class='author'>Helen.zhang</div>
              <time class='date' datetime='2015-07-22T11:51:33+00:00'>22 Jul 15, 11:51</time>
            </div>
            <div class='col-md body'>
              <div id="dvContent" style="font-size: 12px; line-height: 1.6em; color: #464646; word-wrap: break-word; font-family: Arial, Helvetica, sans-serif;">
              <div id="subheadlines" style="font-size: 15px; font-weight: bold; line-height: 1.6em; font-style: italic;">-- TSX Exchange Symbol: RVX</div>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">CALGARY, Alberta </span>/PRNewswire/ -- Resverlogix Corp. ("Resverlogix") (TSX: RVX) announced today that it has closed the previously-announced private placement with Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink") and Eastern Capital Limited ("Eastern").</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">Under the terms of the transaction, Hepalink subscribed for 13,270,000 units, each unit ("Unit") being comprised of one (1) common share and 0.075358 common share purchase warrants, for aggregate proceeds of approximately <span class="xn-money" style="font-family: Arial, 'Times New Roman', Times, serif;">CAD$35 million</span>, or <span class="xn-money" style="font-family: Arial, 'Times New Roman', Times, serif;">CAD$2.67</span> per Unit. Each whole warrant is exercisable into one common share at <span class="xn-money" style="font-family: Arial, 'Times New Roman', Times, serif;">CAD$2.67</span> per share for a period of five years. After giving effect to the transaction, Hepalink holds approximately 12.63% of Resverlogix's common shares. The common shares and warrants issued to Hepalink are subject to a three year lock-up period. Hepalink is also entitled to nominate one mutually agreed representative for election to the board of directors of Resverlogix.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">In addition, Eastern subscribed for 5,600,000 Units for aggregate consideration of approximately <span class="xn-money" style="font-family: Arial, 'Times New Roman', Times, serif;">CAD$15 million</span>, or <span class="xn-money" style="font-family: Arial, 'Times New Roman', Times, serif;">CAD$2.67</span> per Unit. After giving effect to the transaction, Eastern holds approximately 19.57% of Resverlogix's common shares.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong>About Resverlogix</strong></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">Resverlogix Corp. is developing RVX-208, a first-in-class, small molecule selective BET bromodomain inhibitor for the potential treatment of patients with cardiovascular disease, diabetes mellitus, Alzheimer's disease, peripheral artery disease, and chronic kidney disease. RVX-208 is the only selective BET bromodomain inhibitor in clinical trials. Resverlogix's common shares trade on the Toronto Stock Exchange (TSX: RVX). For further information please visit <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="http://www.resverlogix.com/">www.resverlogix.com</a>. We can be followed on our blog at <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="http://www.resverlogix.com/blog">http://www.resverlogix.com/blog</a>and via Twitter <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="https://twitter.com/resverlogix_rvx">https://twitter.com/resverlogix_rvx</a> @Resverlogix_RVX.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">Company Contacts:</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><span class="xn-person" style="font-family: Arial, 'Times New Roman', Times, serif;">Donald J. McCaffrey</span><br>President and CEO <br>Resverlogix Corp. <br>Phone: 403-254-9252<br>Email: <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="mailto:don@resverlogix.com">don@resverlogix.com</a></p>
              </div>
              <div id="dvSource" style="font-size: 12px; margin-top: 25px; margin-bottom: 5px; color: #666666; font-family: Arial, Simsun, Helvetica, sans-serif; line-height: 12px;">Source: Resverlogix Corp.</div>
              <div id="dvTickers" style="margin-top: 15px; color: #464646; font-family: Arial, Simsun, Helvetica, sans-serif; font-size: 12px; line-height: 12px;">
              <h4 class="seo-h4-seemorereleases" style="line-height: 1em; font-size: 12px; font-weight: normal; padding-bottom: 10px; font-family: Arial, 'Times New Roman', Times, serif;">Related stocks: <a style="margin: 0px; color: #6099e9; outline: none;" title="Toronto:RVX" href="http://en.prnasia.com/p/ticker+Toronto+RVX+0.shtml">Toronto:RVX</a></h4>
              </div>
              <div class="dvWebsites" style="line-height: 1.5em; margin-top: 15px; color: #464646; font-family: Arial, Simsun, Helvetica, sans-serif; font-size: 12px;">Related Links:
              <ul style="margin: 0px; list-style: none;">
              <li><a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="http://www.resverlogix.com/">http://www.resverlogix.com</a></li>
              </ul>
              </div>
            </div>
          </div>
        </li>
        <li class='list-group-item'>
          <div id='div-gpt-ad-1528181032761-2' style='height:250px; width:300px;'><script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1528181032761-2');});</script></div>
        </li>
      </ul>
      <nav class='pagination'>
      </nav>
      <footer>
        <nav class='nav'>
          <a class='nav-link' href='/'>Home</a>
          <a class='nav-link' href='/privacy/'>Privacy</a>
          <a class='nav-link' href='/terms/'>Terms</a>
        </nav>
      </footer>
    </div>
    <div id='div-gpt-ad-1528181032761-0' style='height:1px; width:1px;'><script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1528181032761-0');});</script></div>
  </body>
</html>
